Imunon, Inc.
IMNN
$1.98
-$0.04-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.39M | 3.39M | 3.39M | 4.98M | 6.11M |
| Gross Profit | -3.39M | -3.39M | -3.39M | -4.98M | -6.11M |
| SG&A Expenses | 6.87M | 7.01M | 7.10M | 7.76M | 7.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.65M | 14.54M | 16.02M | 18.27M | 19.13M |
| Operating Income | -14.65M | -14.54M | -16.02M | -18.27M | -19.13M |
| Income Before Tax | -14.50M | -14.33M | -15.75M | -17.79M | -18.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.50 | -14.33 | -15.75 | -17.79 | -18.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.50M | -14.33M | -15.75M | -17.79M | -18.62M |
| EBIT | -14.65M | -14.54M | -16.02M | -18.27M | -19.13M |
| EBITDA | -14.36M | -14.28M | -15.78M | -18.03M | -18.89M |
| EPS Basic | -8.15 | -9.82 | -12.41 | -17.19 | -20.35 |
| Normalized Basic EPS | -5.09 | -6.14 | -7.76 | -10.74 | -12.72 |
| EPS Diluted | -8.15 | -9.82 | -12.41 | -17.19 | -20.35 |
| Normalized Diluted EPS | -5.09 | -6.14 | -7.76 | -10.74 | -12.72 |
| Average Basic Shares Outstanding | 8.45M | 6.83M | 5.18M | 4.43M | 4.03M |
| Average Diluted Shares Outstanding | 8.45M | 6.83M | 5.18M | 4.43M | 4.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |